Venture Planning Group: Market Research Reports

Publications found: 60,074

Sort by:

Leading Generic and Specialty Drug Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 9,500.00

In the dynamic and fragmented Generic and Specialty Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions an...

November 2021 -

Leading Healthcare Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological...

November 2021 -

Leading Herbicides Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 2,750.00

This new report from LeadingMarketResearch.com analyzes marketing strategies of the world's leading agrochemical companies. The report provides agrochemical industry executives with strategically sign...

November 2021 -

Leading Internet Retail Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

In the dynamic and fragmented Internet Retail industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing...

November 2021 -

Leading Metals and Mining Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

In the dynamic and fragmented Metals and Mining industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketi...

November 2021 -

Leading MRI Suppliers to Watch in 2022-Capabilities, Goals and Strategies

US$ 7,400.00

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective busin...

November 2021 -

Leading Oil and Gas Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

November 2021 -

Leading Paint and Coatings Suppliers to Watch in 2022-Capabilities, Goals and Strategies

US$ 3,450.00

This report from LeadingMarketResearch.com provides analysis of the world paint and coatings market outlook, as well as leading supplier business strategies and marketing tactics. The report presents...

November 2021 -

Leading Paper Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

November 2021 -

Leading Pharmaceutical Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

November 2021 -

Leading Plastics Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 3,500.00

November 2021 -

Leading Ultrasound Suppliers to Watch in 2022-Capabilities, Goals and Strategies

US$ 9,500.00

The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. This unique study is designed to provide diagnostic imaging indus...

November 2021 -

Leading X-Ray Equipment Suppliers to Watch in 2022-Capabilities, Goals and Strategies

US$ 7,400.00

November 2021 -

Top 10 Chemical Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,850.00

This report is available by section, and can be customized to specific objectives, information needs and budget. The Top 10 report analyzes the following companies:BASFDowExxonMobilFormosaIneosLindeLy...

November 2021 -

Top 10 Household Products and Personal Care Companies to Watch in 2022-Capabilities, Goals and Strategies

US$ 4,500.00

November 2021 -

2021-2025 Asia-Pacific Tumor Markers Business Opportunities in 17 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...

November 2021 -

2021-2025 Europe Tumor Markers Business Opportunities-France, Germany, Italy, Spain, UK-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in major...

November 2021 -

2021-2025 Europe Tumor Markers Business Opportunities in 38 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 24,500.00

This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...

November 2021 -

2021-2025 France Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 3,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the Fre...

November 2021 -

2021-2025 Germany Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 3,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the Ger...

November 2021 -

2021-2025 Global Tumor Markers Business Opportunities-USA, Europe, Japan-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 24,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S...

November 2021 -

2021-2025 Italy Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 3,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the It...

November 2021 -

2021-2025 Japan Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 3,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years. The report examines trends in the J...

November 2021 -

2021-2025 Latin America Tumor Markers Business Opportunities in 22 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...

November 2021 -

2021-2025 Middle East Tumor Markers Business Opportunities in 11 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 9,500.00

This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...

November 2021 -

2021-2025 North America Tumor Markers Business Opportunities-USA, Canada, Mexico-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 9,500.00

This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific inf...

November 2021 -

2021-2025 Spain Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 3,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years. The report examines trends in the Sp...

November 2021 -

2021-2025 U.K. Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 3,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK canc...

November 2021 -

2021-2025 U.S. Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 3,500.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S....

November 2021 -

2021-2025 World Tumor Markers Business Opportunities in 97 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 34,500.00

This new 97-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. The report is available by section, and can be customized to spe...

November 2021 -

Asia-Pacific Molecular Diagnostics Market Assessment of 17 Countries-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market en...

November 2021 -

Europe Molecular Diagnostics Market Assessment-France, Germany, Italy, Spain, UK-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 17,500.00

This new comprehensive five-country report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities eme...

November 2021 -

Europe Molecular Diagnostics Market Assessment of 38 Countries-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 24,500.00

This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market en...

November 2021 -

Global Molecular Diagnostics Market Assessment-US, Europe, Japan-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 24,500.00

This new seven-country study from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molec...

November 2021 -

Latin America Molecular Diagnostics Market Assessment of 22 Countries-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market en...

November 2021 -

Middle East Molecular Diagnostics Market Assessment of 11 Countries-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 9,500.00

This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market en...

November 2021 -

North America Molecular Diagnostics Market Assessment of the US, Canada and Mexico-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 9,500.00

This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market ent...

November 2021 -

Asia-Pacific Hematology and Flow Cytometry Analyzer and Reagent Markets, 2021-2025-Supplier Shares, Segment Forecasts, Growth Opportunities in 17 Countries—Competitive Strategies, Instrumentation Pipeline, Latest Technologies

US$ 14,500.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. This new 17-country report from LeadingMarketResearch.com is available...

November 2021 -

Global Hematology and Flow Cytometry Analyzer and Reagent Markets, 2021-2025-Supplier Shares, Segment Forecasts, Growth Opportunities in the US, Europe, Japan—Competitive Strategies, Instrumentation Pipeline, Latest Technologies

US$ 18,500.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. This comprehensive seven-country report is designed to help current su...

November 2021 -

Latin America Hematology and Flow Cytometry Analyzer and Reagent Markets, 2021-2025-Supplier Shares, Segment Forecasts, Growth Opportunities in 22 Countries—Competitive Strategies, Instrumentation Pipeline, Latest Technologies

US$ 14,500.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. This new 22-country report from LeadingMarketResearch.com is available...

November 2021 -

Middle East Hematology and Flow Cytometry Analyzer and Reagent Markets, 2021-2025-Supplier Shares, Segment Forecasts, Growth Opportunities in 11 Countries—Competitive Strategies, Instrumentation Pipeline, Latest Technologies

US$ 9,500.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. This new 11-country report from LeadingMarketResearch.com is available...

November 2021 -

North America Hematology and Flow Cytometry Analyzer and Reagent Markets, 2021-2025-Supplier Shares, Segment Forecasts, Growth Opportunities in the US, Canada, Mexico—Competitive Strategies, Instrumentation Pipeline, Latest Technologies

US$ 9,700.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. This new 3-country report from LeadingMarketResearch.com is available...

November 2021 -

World Hematology and Flow Cytometry Analyzer and Reagent Markets, 2021-2025-Supplier Shares, Segment Forecasts, Growth Opportunities in 97 Countries—Competitive Strategies, Instrumentation Pipeline, Latest Technologies

US$ 35,000.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

November 2021 -

2021-2025 Asia-Pacific Hemostasis Market Opportunities-A 17-Country Analysis-Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts-Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

November 2021 -

2021-2025 Asia-Pacific Immunodiagnostics Market Perspective for 17 Countries—Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

November 2021 -

2021-2025 Asia-Pacific Virology and Bacteriology Market for over 100 Tests: A 17-Country Analysis-Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation, Opportunities

US$ 14,500.00

This new report from LeadingMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as co...

November 2021 -

2021-2025 Europe Hemostasis Market Opportunities-A 38-Country Analysis-Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts-Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 24,500.00

This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report explores business and technological trends; provides test vol...

November 2021 -

2021-2025 Europe Hemostasis Market Opportunities-France, Germany, Italy, Spain, UK-Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts-Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing ma...

November 2021 -

2021-2025 Europe Immunodiagnostics Market Perspective for 38 Countries—Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 24,500.00

November 2021 -

2021-2025 Europe Immunodiagnostics Market Perspective-France, Germany, Italy, Spain, UK-Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer Diagnostic, Endocrine, Immunoprotein, TDM, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

US$ 14,500.00

LeadingMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the European immunodiagnostic market during the next five years. The report is a...

November 2021 -

Filters

Clear all

Publishers

Venture Planning Group

60,074

Price

—

Date

—

Pages

—

Offers